Form4insider filings, from the source

SEC Form 4 · accession 0001104659-17-025040

Sorrento Therapeutics, Inc. · SRNE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owners
Fan Yu
10% Owner
Bin Li
10% Owner
ABG SRNE Ltd
10% Owner
ABG II-SO Ltd
10% Owner
Period of report
Apr 19, 2017
Accepted (ET)
Apr 21, 2017 · 7:16 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000850261

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3,F5Apr 19, 2017P550,000$2.00A1,991,441IThrough Ally Bridge LB Healthcare Master Fund Limited See footnote
Common StockF1,F2,F3,F4holding———1,397,853IThrough ABG II-SO Limited See footnote
Common StockF1,F2,F3,F6holding———3,243,242IThrough ABG SRNE Limited See footnote
Common StockF1,F2,F3,F7holding———1,500,000IThrough ABG Innovation-SO Limited See footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
WarrantsF1,F2,F3,F5,F8$8.50holding————May 31, 2019Common Stock432,432432,432I
WarrantsF1,F2,F3,F6,F8$8.50holding————May 31, 2019Common Stock432,432432,432I
WarrantsF1,F2,F3,F6,F9$8.50holding————Jun 7, 2019Common Stock540,540540,540I

Explanation of responses